Evidence map›Paper›PMID 40723994›Full record

ReviewAntibiotics (Basel, Switzerland)2025

Harnessing the Potential of Antibacterial and Antibiofilm Phytochemicals in the Combat Against Superbugs: A One Health Perspective.

Suma Sarojini, Saranya Jayaram, Sandhya Kalathilparambil Santhosh, Pragyan Priyadarshini, Manikantan Pappuswamy, Balamuralikrishnan Balasubramanian

Abstract readReview
In one paragraph

Review in Antibiotics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Evaluation ofMolecules (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Suma SarojiniDepartment of Life Sciences, CHRIST (Deemed to be University), Bangalore 560029, Karnataka, India.ORCID 0000-0002-5686-8330
Saranya JayaramDepartment of Biotechnology, Mount Carmel College, Autonomous, Bangalore 560001, Karnataka, India.
Sandhya Kalathilparambil SanthoshDepartment of Biotechnology, Mount Carmel College, Autonomous, Bangalore 560001, Karnataka, India.
Pragyan PriyadarshiniDepartment of Life Sciences, CHRIST (Deemed to be University), Bangalore 560029, Karnataka, India.ORCID 0000-0002-0701-9324
Manikantan PappuswamyDepartment of Life Sciences, CHRIST (Deemed to be University), Bangalore 560029, Karnataka, India.ORCID 0000-0002-6047-3702
Balamuralikrishnan BalasubramanianDepartment of Food Science and Biotechnology, College of Life Science, Sejong University, Seoul 05006, Republic of Korea.ORCID 0000-0001-6938-1495

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The war between humans and bacteria started centuries ago. With the advent of antibiotics, there was a temporary ceasefire in this war, but the scenario soon started becoming worse with the emergence of drug-resistant strains within years of the deployment of antibiotics in the market. With the surge in the misuse of antibiotics, there was a drastic increase in the number of multidrug-resistant (MDR) and extensively drug-resistant bacterial strains, even to antibiotics like Methicillin and vancomycin, aggravating the healthcare scenario. The threat of MDR ESKAPE pathogens is particularly high in nosocomial infections, where biofilms formed by bacteria create a protective barrier that makes them highly resistant to antibiotics, complicating the treatment efforts. Scientists are looking at natural and sustainable solutions, as several studies have projected deaths contributed by drug-resistant bacteria to go beyond 50 million by 2050. Many plant-derived metabolites have shown excellent antibacterial and antibiofilm properties that can be tapped for combating superbugs. The present review explores the current status of various studies on antibacterial plant metabolites like alkaloids and flavonoids and their mechanisms in disrupting biofilms and killing bacteria by way of inhibiting key survival strategies of bacteria like motility, quorum-sensing, reactive oxygen species production, and adhesion. These mechanisms were found to be varied in Gram-positive, Gram-negative, and acid-fast bacteria like

Indexed as

antibacterialantibiofilmphytochemicalsquorum sensingsuperbugs

Identifiers

PMID40723994
PMCPMC12291804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.